Birmingham, West Midlands -- (SBWIRE) -- 01/22/2014 -- Value Penny Stocks issues special report on BlackBerry Ltd (NASDAQ:BBRY), Cereplast Inc (OTCMKTS:CERP), Sirius XM Holdings Inc. (NASDAQ:SIRI), Cell Therapeutics Inc (NASDAQ:CTIC).
BlackBerry Ltd (NASDAQ:BBRY) ended its recent business day with the gain of 9.36% and closed at the price of $9.93 after opening at $9.90. The stock traded during its last trading session with the total volume of 71.83 million shares, as compared to its average volume of 29.39 million shares. BlackBerry Limited engages in the design, manufacture, and marketing of wireless solutions worldwide. It provides platforms and solutions for access to email, voice, instant messaging, short message service, Internet and Intranet-based applications, and browsing through the development of integrated hardware, software, and services.
Will BBRY Continue To Move Higher? Find Out Here
Cereplast Inc (OTCMKTS:CERP) remained among the day decliners and traded with volume of 45.81 million shares in the last session, as compared to average volume of 17.14 million shares. In comparison with 52 week range of $0.00 - $0.07, it faced lowest price of $0.00 during the last trading session whereas its day highest price was $0.01. The company’s total market capitalization is $5.37 billion, along with 994.9 million shares outstanding. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
Has CERP Found The Bottom And Ready To Gain Momentum? Find Out Here
Sirius XM Holdings Inc. (NASDAQ:SIRI) showed 35,997,824 shares in volume during the last trading session, while the average trading volume remained 68,102,700 shares. The stock kicked off its trading session at $3.74 and closed at $3.71 after declining 0.13%. Sirius XM Holdings Inc. provides satellite radio services in the United States and Canada. The company creates and broadcasts commercial-free music; sports talk and live events; comedy; news; exclusive talk and entertainment; and the comprehensive Latin music, sports, and talk programming in radio.
Why Should Investors Buy SIRI After the Recent Fall? Just Go Here and Find Out
Cell Therapeutics Inc (NASDAQ:CTIC) stock traded during its last trading session with the total traded volume of 24.19 million shares versus its average volume of 4.39 million shares. The company opened its trade at the price of $4.01 and its closing price was $4.21 after gaining 15.66% for the day. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
Why Should Investors Buy CTIC After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)